Brain Research · 1991 · 457 citations · 27 references
MedicineNeurosciencePharmacologyNeurochemistryNeuropharmacologyPsychopharmacologyAnxiolytic PharmacologyBehavioral EndocrinologyGabaergic NeurochemistryGabaergic PharmacologyReproductive NeuroendocrinologyAnxiolytic ActionLocomotor Activity PatternsProgesterone PharmacodynamicsProgesterone Pharmacology
The effects of intracerebroventricular administration of reduced metabolites of progesterone on locomotor activity and on exploration in the elevated plus-maze were assessed in adult female rats. Allopregnanolone (3 alpha-hydroxy-5 alpha-pregnan-20-one; 1.25, 5.0, and 10 micrograms) and pregnanolone (3 alpha-hydroxy-5 beta-pregnan-20-one; 2.5, 5.0, and 10 micrograms) elicited anxiolytic effects and, at the highest dose tested, allopregnanolone resulted in sedation. In contrast, the 3 beta-hydroxy-epimer of allopregnanolone was without effect in either behavioral paradigm. The anxiolytic response to pregnanolone was blocked by picrotoxin (0.75 mg/kg, i.p.), a dose that by itself did not affect behavior in the plus-maze. These data suggest that the anxiolytic effect of 3 alpha-hydroxy metabolites of progesterone is mediated by brain GABAA receptors in a stereospecific manner, and are in good agreement with the well-documented in vitro effects of these steroids as potent modulators of the GABAA receptor.
27
Steroid Hormone Metabolites Are Barbiturate-Like Modulators of the GABA Receptor
Maria Dorota Majewska, Neil L. Harrison, Rochelle D. Schwartz et al. · Science · 1986 · 2.2K citations
Medicine, Neuroscience, Pharmacology +17
Neurosteroids act on recombinant human GABAA receptors
Giulia Puia, Mariarita Santi, Stefano Vicini et al. · Neuron · 1990 · 523 citations · Full text
Kelvin W. Gee, Michael B. Bolger, Roberta Dı́az Brinton et al. · Journal of Pharmacology and Experimental Therapeutics · 1988 · 467 citations